Current conservative management of Osteoarthritis, lack of DMAODs, and failure to translate past clinical trial stage

This research explores the management of osteoarthritis (OA), addressing symptom-modifying drugs and existing disease management options. It highlights the absence of disease-modifying drugs, reflecting on the challenges in drug development, including the frequent failure of novel therapies in clinical trials and the significant financial investments yielding limited progress.